| 000 | 01835cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030922.0 | ||
| 008 | 140104s2013 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.08.09.M.Sc.2013.Sa.P | ||
| 100 | 0 | _aSamar Mohammed Suliman Ibrahim | |
| 245 | 1 | 0 |
_aPharmacological study on the effect of vitamin E succinate and doxorubicin in experimental animals / _cSamar Mohammed Suliman Ibrahim ; Supervised Dalaal M. Abdallah , Samia A. Shouman , Hafez Farouk |
| 246 | 1 | 5 | _aالدراسة الدوائية لتاثير سكسينات فيتامين هـ والدوكسوروبيسين عند اعطائهم لحيوانات التجارب |
| 260 |
_aCairo : _bSamar Mohammed Suliman Ibrahim , _c2013 |
||
| 300 |
_a106 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmacology and Toxicology | ||
| 520 | _aDoxorubicin (DXR) is widely used in the treatment of many human cancers but unfortunately it causes various toxic effects and a significant number of patients develop resistance . Vitamin E succinate (VES) redox - silent analogue of vitamin E is a promising anti- cancer agent . The present study aimed to examine the combined effect of VES and DXR regarding toxicity and antitumor activity in animals | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aDoxorubicin | |
| 653 | 4 | _aTissue homogenate | |
| 653 | 4 | _aVitamin E succinate | |
| 700 | 0 |
_aDalaal Moustafa Abdallah , _eSupervisor |
|
| 700 | 0 |
_aHafez Farouk , _eSupervisor |
|
| 700 | 0 |
_aSamia Abdelsamea Shouman , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c44708 _d44708 |
||